Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells-Reference-Cited by-同舟云学术

Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells

Published:2016-04 Issue:4 Volume:27 Page:286-299
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Dong Xinjun,Liu Feiyan,Li Mianli

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference38 articles.

1. Chemotherapy and target therapy for hepatocellular carcinoma: new advances and challenges.;Deng;World J Hepatol,2015

2. Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age.;Miyahara;World J Gastroenterol,2014

3. Improved chemotherapy for hepatocellular carcinoma.;Cao;Anticancer Res,2012

4. Treatment of advanced hepatocellular carcinoma with emphasis on hepatic arterial infusion chemotherapy and molecular targeted therapy.;Kudo;Liver Cancer,2012

5. NF-B and STAT3 - key players in liver inflammation and cancer.;He;Cell Res,2011

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural products reverse cisplatin resistance in the hypoxic tumor microenvironment;Cancer Letters;2024-08

2. In vitro identification of oridonin hybrids as potential anti-TNBC agents inducing cell cycle arrest and apoptosis by regulation of p21, γH2AX and cleaved PARP;RSC Medicinal Chemistry;2024

3. Design and synthesis of oridonin derivatives as cytotoxic agents;Natural Product Research;2023-10-30

4. The Natural Product Oridonin as an Anticancer Agent: Current Achievements and Problems;Current Pharmaceutical Biotechnology;2023-08-21

5. Signal-amplified detection of biomarker transcription factors with improved accuracy based on T4 DNA ligase protection and rolling circle amplification;Sensors and Actuators B: Chemical;2022-06